The weekly litigation news digest is live. Subscribe now

Tetraphase Pharmaceuticals competitive analysis

Explore patent oppositions filed by Tetraphase Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 1, 2026
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by Tetraphase Pharmaceuticals

Crystalline Eravacycline Bis-HydrochlorideSANDOZJun 22, 2021

Explore Tetraphase Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jan 1, 2026
Patent NumberPublication DateTitleTotal Oppositions

Get instant alerts of patent oppositions faced by Tetraphase Pharmaceuticals

Oct 18, 2017C7-Fluoro Substituted Tetracycline Compounds1

Latest PTAB cases involving Tetraphase Pharmaceuticals

Discover the latest PTAB cases involving Tetraphase Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Tetraphase Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 1, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TETRAPHASE PHARMACEUTICALS11 - -
SANDOZ1201619 -